Matthew Lin is a health care deal lawyer that handles complex corporate transactions and related regulatory issues. Matt’s practice draws on his understanding of the unique and rapidly developing legal risks facing members of the health care industry. He manages acquisitions and divestitures of various health care providers, including:

  • Hospitals
  • Physician practices
  • Home health and hospice agencies
  • Long-term care facilities
  • Optometry
  • Physical therapy
  • Behavioral health 

Matt advises clients on the regulatory challenges that impact health care deals, such as fraud and abuse laws, corporate practice of medicine and licensure issues. Matt has extensive experience in managing the potential disclosure of health care deals to state regulators like California’s Office of Health Care Affordability (OHCA) and the Oregon Health Authority (OHA) under state “Mini-HSR” laws.

Before joining Polsinelli, Matt worked on white collar investigations and litigation matters at an international law firm. His work involved matters critical to the health care and life sciences industries, such as the Anti-Kickback Statute, the Federal and California False Claims Acts, health care fraud, the California Knox Keene Act and the Controlled Substances Act. During law school, Matt externed with the Criminal Division of the United States Attorney’s Office for the Central District of California. He also served on the boards of the Harvard Asian Pacific American Law Students Association and the Harvard Prison Legal Assistance Project.

Education

  • Harvard Law School (J.D., 2019)
    • California State University (B.A., summa cum laude, 2015)

      Bar Admission

      • California

      Professional Affiliations

      • Leadership Council on Legal Diversity (LCLD)
        • 2025 Pathfinder
      • Asian Pacific American Bar Association of Los Angeles County
        • Board Member
      • American Health Law Association
      Publications
      OHCA Publishes Draft Regulations Implementing AB 1415 to Capture Health Care Transactions with Private Equity, Hedge Funds and MSOs
      Key Takeaways OHCA has published draft regulations that expand its pre-transaction notice requirements to transactions involving private equity groups, hedge funds, certain management services organizations and newly created entities entering into transactions with health care entities. OHCA also proposed revised standards and procedures in its existing regulations, including adding information and documents to be disclosed and refining the procedures for conducting Cost and Market Impact Reviews. Among other focuses, the proposed regulations demonstrate OHCA’s interest in details of the arrangements between private equity groups and California health care entities and the impact of transactions on real estate where health care is delivered. Some of the new standards and requirements bear a notable resemblance to language used in some terms of the recent proposed
      Read More
      California AG Settlement Signals Heightened Scrutiny of Corporate Practice of Medicine and Dentistry
      Key Takeaways: California’s Attorney General opened a new front in the state’s war against private equity-backed PC/MSO1 arrangements through its recent settlement with a dental services organization. The settlement reaches far beyond recent legislative action and demands careful attention from operators in this space. While the settlement does not create any binding legal precedent, investors and operators in PC/MSO structures involving licensed professionals should evaluate their existing operations in light of the settlement framework — with a particular emphasis on licensed professional control of clinical decisions. Careful attention to public communications, advertising, marketing and branding is more important than ever, as the settlement reinforces that consumer-facing statements may draw scrutiny where they suggest control over clinical services, provider relationships or practice operations. California regulators are
      Read More